MJNA’s HempMeds Reveals Several New Cannabis Products to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MJNA’s HempMeds Reveals Several New Cannabis Products to Anti-Aging Doctors at A4M World Congress

SAN DIEGO, Calif., Dec. 04, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) announces to shareholders and the general public that their portfolio Companies HempMeds® and Kannaway, LLC are proudly showcasing their newly expanded hemp cannabidiol (CBD) oil product lines at the 23rd Annual World Congress on Anti-Aging Medicine.

This year’s American Academy of Anti-Aging Medicine (A4M) World Congress takes place December 10-13 at the Venetian/Palazzo Hotel in Las Vegas. The A4M global conference on anti-aging, regenerative and aesthetic medicine markets to more than 26,000 members including: physicians, health practitioners, scientists, governmental officials and members of the general public, representing more than 110 nations.

“We are fortunate to have the opportunity to attend another A4M Conference. We have developed some wonderful new CBD hemp oil products, including RSHO’s™ incredibly concentrated 38% special blend oral applicator and blends with MCT oil. The A4M is the perfect forum to launch our impressive new product lines,” says Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc.

Patent No. 6630507 , awarded to the U.S. Department of Health and Human Services states that cannabinoids have been found to have antioxidant and anti-aging properties. According to A4M , ninety million adult Americans use alternative medicine, with the global market estimated to be worth $292 billion by the end of the year. 

Real Scientific Hemp Oil™ (RSHO™) 38% Special Blend Consumers can now access the most concentrated form of RSHO™ to date. The special blend is provided in an oral applicator tube that is packed with more CBD content than ever before.

Real Scientific Hemp Oil™ Liquid Each bottle of RSHO™ Liquid contains 1,000mg of CBD, and is combined with MCT oil. The MCT, or medium-chain triglyceride, oil in RSHO™ Liquid is derived from coconut oil as well as sustainably sourced palm oil.

Real Scientific Hemp Oil™ Tinctures The convenient tinctures feature the new MCT oil formulation. RSHO™ tinctures contain 100mg and 500mg of CBD respectively, and feature MCT 60/40 oil (60% Caprylic Acid and 40% Capric Acid).

Real Scientific Hemp Oil™ Capsules Each all-natural RSHO™ Capsule contains 25mg of CBD, as well as 200mg of calcium, and 200mg of a proprietary blend of powdered turmeric root and white willow bark - all combined in a vegan delayed-release capsule.

Real Scientific Hemp Oil™ Salve Formulated with CBD hemp oil, almond oil, beeswax, camphora essential oil, and our unique herbal extract. Each jar contains 50mg of CBD from natural, sustainable hemp oil.

Kannaway, LLC’s NEW Balance12 ™ A Complete Detox and Maintenance System. Bring balance to your life all 12 months of the year with Kannaway’s full time detox system.

Kannaway, LLC’s Rev!ve Further your daily regimen with: extra strength Rev!ve Pro, the Cannabis Beauty Defined Capsules, Rev!ve Mid-day Capsules, soothing Rev!ve PM, and the amazing Rev!ve Salve.

While at A4M, attendees can visit booth #4090 for more information on these and other exciting products. People wishing to attend this conference should visit the A4M website for admission requirements.

We encourage MJNA’s more than 100,000 shareholders to go Medical Marijuana Inc’s website and register to receive our products at special rate.

In the U.S., hemp is widely regarded as a “whole food” and “superfood.” Medical Marijuana, Inc.'s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC. Non-GMO RSHO™ contains no pesticides, herbicides or heavy metals. Before becoming a finished product, RSHO™ goes through multiple quality tests by top cannabis industry and food laboratories .

About HempMeds ® HempMeds ® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Kannaway, LLC Kannaway , LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana Inc. The mission of Medical Marijuana, Inc. (OTC:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

 

For further information, please contact: Public Relations contact: Andrew Hard at CMW Media Chief Executive Officer (917) 660-5418 andrew.hard@cmwmedia.com www.CMWMedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 136

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
COhatch Preps for High-Stakes Ohio Pitch Contest

Updated Category News Views 31

Ohio Startups Gear Up for Another Fierce Faceoff You wouldn't find me betting against a hungry entrepreneur, especially with $25,000 on the line. That's the prize dangling at this year's Dublin Pitch Competition, hosted by COhatch and the City of Dublin. If there's one thing I'm certain of, it's that Ohio will see some real contenders stepping up on October 15....

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading

Top 5 Most Recently Viewed Articles

i3 Verticals' Strategic Shift Boosts Confidence in Future Growth

Updated Category News Views 53

i3 Verticals' Strategic Transformation Enhances Market Position i3 Verticals (NASDAQ: IIIV), recognized for providing integrated payment and software solutions, has recently received a boost in market confidence following the announcement of its significant $438 million divestiture. This strategic decision marks a pivotal moment for the company, allowing it to sharpen its...

Continue Reading
Understanding the Transformative Role of Placental Tissue for Healing

Updated Category News Views 93

Exploring the Benefits of Placental Allografts Marietta, GA – MiMedx Group, Inc. (NASDAQ: MDXG) has recently spotlighted the insights shared in a feature article about placental allografts, which focus on their application for healing complex wounds. This discussion surfaced through a compelling article in a major publication, highlighting the incredible advantages...

Continue Reading
Celebrate Impact: 13 Independent Coffee Shops Thriving Together

Updated Category News Views 326

Crimson Cup Supports Anniversaries of 13 Independent Coffee Shops Crimson Cup Coffee & Tea is proud to acknowledge the special anniversaries of 13 independent coffee houses this month. These remarkable shops are located in various states and have embraced their milestones, ranging from one year to an impressive 13 years of serving delicious coffee. The success these...

Continue Reading
Exploring Key UK Economic Trends Forecasted for 2025

Updated Category News Views 254

Insights on UK Economic Trends for 2025 The new year has arrived, and Deutsche Bank (ETR: DBKGn) has highlighted eight vital themes expected to influence the UK economy as we move further into 2025. Despite current uncertainties, analysts from Deutsche Bank express a level of optimism, indicating that government spending is likely to become a significant contributor to...

Continue Reading
Centene Corporation Reports Impressive Financial Results for 2024

Updated Category News Views 1146

Centene Corporation's Stellar 2024 Financial Overview Centene Corporation (NYSE: CNC) showcased robust financial performance for the year 2024, highlighted by a significant increase in diluted earnings per share (EPS) and revenue growth across various segments. The company's diluted EPS rose to $6.31, with an adjusted diluted EPS reaching $7.17, reflecting a 7% increase...

Continue Reading